Dr James A Hopfenback, MD | |
6750 W 52nd Ave, Suite F, Arvada, CO 80002-3956 | |
(720) 898-3300 | |
(720) 898-3333 |
Full Name | Dr James A Hopfenback |
---|---|
Gender | Male |
Speciality | Pathology |
Experience | 37 Years |
Location | 6750 W 52nd Ave, Arvada, Colorado |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1417936857 | NPI | - | NPPES |
01316090 | Medicaid | CO |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | DR31609 (Colorado) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Uchealth Yampa Valley Medical Center | Steamboat springs, CO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Colorado Pathology Consultants Pc | 2264323096 | 13 |
News Archive
The use of animals in biomedical research has long been the focus of campaigns by animal rights activists. Two leading scientists writing in the European Journal of Internal Medicine give their expert view of the importance of animal testing to medical progress and present ways it could be further improved to yield more useful clinical results.
A recent retrospective matched cohort study of more than 9,000 pregnant women found that women who received group prenatal care had a significantly lower risk of having a preterm birth or a low birth weight baby compared with women who received individual care only, after adjusting for number of individual care visits.
The Wall Street Journal on Monday examined how some hospitals are "adopting a policy to improve their finances: making medical care contingent on upfront payments."
Pfizer Inc. announced today that it has initiated the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for crizotinib (PF-02341066), an oral first-in-class anaplastic lymphoma kinase (ALK) inhibitor for the treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors are ALK-positive. Pfizer expects to complete the submission in the first half of 2011.
› Verified 8 days ago
Entity Name | Colorado Pathology Consultants Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1124090154 PECOS PAC ID: 2264323096 Enrollment ID: O20040326000631 |
News Archive
The use of animals in biomedical research has long been the focus of campaigns by animal rights activists. Two leading scientists writing in the European Journal of Internal Medicine give their expert view of the importance of animal testing to medical progress and present ways it could be further improved to yield more useful clinical results.
A recent retrospective matched cohort study of more than 9,000 pregnant women found that women who received group prenatal care had a significantly lower risk of having a preterm birth or a low birth weight baby compared with women who received individual care only, after adjusting for number of individual care visits.
The Wall Street Journal on Monday examined how some hospitals are "adopting a policy to improve their finances: making medical care contingent on upfront payments."
Pfizer Inc. announced today that it has initiated the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for crizotinib (PF-02341066), an oral first-in-class anaplastic lymphoma kinase (ALK) inhibitor for the treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors are ALK-positive. Pfizer expects to complete the submission in the first half of 2011.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr James A Hopfenback, MD 14275 Midway Rd, Suite 400, Addison, TX 75001-3614 Ph: (214) 932-8029 | Dr James A Hopfenback, MD 6750 W 52nd Ave, Suite F, Arvada, CO 80002-3956 Ph: (720) 898-3300 |
News Archive
The use of animals in biomedical research has long been the focus of campaigns by animal rights activists. Two leading scientists writing in the European Journal of Internal Medicine give their expert view of the importance of animal testing to medical progress and present ways it could be further improved to yield more useful clinical results.
A recent retrospective matched cohort study of more than 9,000 pregnant women found that women who received group prenatal care had a significantly lower risk of having a preterm birth or a low birth weight baby compared with women who received individual care only, after adjusting for number of individual care visits.
The Wall Street Journal on Monday examined how some hospitals are "adopting a policy to improve their finances: making medical care contingent on upfront payments."
Pfizer Inc. announced today that it has initiated the rolling submission of a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for crizotinib (PF-02341066), an oral first-in-class anaplastic lymphoma kinase (ALK) inhibitor for the treatment of patients with advanced non-small cell lung cancer (NSCLC) whose tumors are ALK-positive. Pfizer expects to complete the submission in the first half of 2011.
› Verified 8 days ago
Dr. Mary E Corkill, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 6750 W 52nd Ave, Arvada, CO 80002 Phone: 720-898-3300 Fax: 720-898-3333 | |
Lorraine Pan, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 6750 W 52nd Ave, Arvada, CO 80002 Phone: 720-898-3300 Fax: 720-898-3333 | |
Dr. Richard C Olshock, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 6750 W 52nd Ave, Suite F, Arvada, CO 80002 Phone: 720-898-3300 Fax: 720-898-3333 | |
Dr. Donald W Heinig, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 6750 W 52nd Ave, Suite F, Arvada, CO 80002 Phone: 720-898-3300 Fax: 720-898-3333 | |
Dr. Michele Kathryn Mcelroy, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 6750 W 52nd Ave, Suite F, Arvada, CO 80002 Phone: 720-898-3300 | |
Dr. William F Cox, MD Pathology Medicare: Not Enrolled in Medicare Practice Location: 6750 W 52nd Ave, Suite F, Arvada, CO 80002 Phone: 720-898-3300 Fax: 720-898-3333 |